The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.

CLIN CLINIGEN GROUP PLC ORD 0.1P




We are now using data from FTSE Russell Data Solutions. FTSE Russell is a leading global provider of benchmarks, analytics and data solutions with multi-asset capabilities. Global Company Fundamentals provides profiles on global active and inactive companies from over 100 countries including over 25 years of as-reported financials and standardised financials based on globally accepted XBRL taxonomies for active companies. As a result of this change in data provider, you may see some differences to the data. For further information please contact lse-website@lseg.com
Income Statement 30-Jun-13
( £ m )
30-Jun-14
( £ m )
30-Jun-15
( £ m )
30-Jun-16
( £ m )
30-Jun-17
( £ m )
Continuing Operations
Revenue  122.58 126.64 184.36 339.90 302.30
Operating Profit/(Loss)  14.60 21.52 9.18 20.20 44.80
Net Interest  -0.09 -0.23 -0.82 -3.50 -1.70
Profit Before Tax  14.51 21.28 8.36 15.50 13.30
Profit After Tax  11.33 16.21 5.68 13.10 3.00
Discontinued Operations
Profit After Tax  n/a n/a n/a n/a n/a
PROFIT FOR THE PERIOD  11.33 16.21 5.68 13.50 3.80
Attributable to:
Minority Interests  n/a n/a n/a n/a n/a
Equity Holders of Parent Company  11.33 16.21 5.68 13.50 3.80
 
Continuing EPS
Earnings per Share - Basic  15.10p 19.60p 6.50p 11.90p 3.30p
Earnings per Share - Diluted  13.80p 19.00p 6.30p 11.80p 3.20p
Earnings per Share - Adjusted  n/a n/a n/a n/a n/a
Continuing and Discontinued EPS
Earnings per Share - Basic  15.10p 19.60p 6.50p 11.90p 3.30p
Earnings per Share - Diluted  13.80p 19.00p 6.30p 11.80p 3.20p
Earnings per Share - Adjusted  n/a n/a n/a n/a n/a
 
Dividend per Share  n/a n/a n/a n/a n/a

Balance Sheet 30-Jun-13
( £ m )
30-Jun-14
( £ m )
30-Jun-15
( £ m )
30-Jun-16
( £ m )
30-Jun-17
( £ m )
Assets
Non-Current Assets
Property, Plant & Equipment  0.75 0.97 1.60 2.70 3.30
Intangible Assets  38.89 50.51 308.22 333.70 332.50
Investment Properties  n/a n/a n/a n/a n/a
Investments  n/a n/a n/a 7.40 8.70
Other Financial Assets  n/a n/a n/a n/a n/a
Other Non-Current Assets  0.00 0.00 0.00 0.00 0.00
  41.62 53.43 313.66 347.30 348.10
Current Assets
Inventories  3.15 2.47 11.13 16.00 16.70
Trade & Other Receivables  11.99 22.64 61.01 67.40 65.40
Cash at Bank & in Hand  11.33 21.79 27.75 27.80 27.80
Current Asset Investments  n/a n/a n/a n/a 0.00
Other Current Assets  0.00 0.00 0.00 0.00 1.00
  37.13 51.43 106.01 112.60 111.40
 
Total Assets  78.75 104.86 419.67 459.90 459.50
 
Liabilities
Current Liabilities
Borrowings  n/a 16.50 69.47 70.00 45.50
Other Current Liabilities  21.56 11.78 43.96 25.70 71.40
  27.80 38.56 161.52 164.30 171.70
 
Net Current Assets  9.33 12.88 -55.52 -51.70 -60.30
 
Non-Current Liabilities
Borrowings  0.00 0.00 34.53 25.90 17.30
Provisions  n/a n/a n/a n/a n/a
Other Non-Current Liabilities  n/a n/a 0.00 11.00 1.30
  n/a n/a 53.52 59.10 38.70
 
Other Liabilities  n/a n/a n/a n/a n/a
Total Liabilities  27.80 38.56 215.04 223.40 210.40
 
Net Assets  50.95 66.31 204.62 236.50 249.10
 
Capital & Reserves
Share Capital  0.08 0.08 0.11 0.10 0.10
Share Premium Account  8.66 8.66 141.02 160.70 161.20
Other Reserves  n/a n/a n/a n/a n/a
Retained Earnings  36.68 52.62 58.35 69.90 71.60
Shareholders Funds  50.95 66.31 204.62 236.50 249.10
 
Minority Interests/Other Equity  n/a n/a n/a n/a n/a
Total Equity *   50.95 66.31 204.62 236.50 249.10

Ratios - based on IFRS 30-Jun-13 30-Jun-14 30-Jun-15 30-Jun-16 30-Jun-17
Continuing Operations
PE Ratio *   19.87 19.27 95.92 50.84 260.91
PEG *   1.38 0.65 -1.44 0.62 -3.61
Earnings per Share Growth  14.39% 29.80% -66.84% 82.58% -72.19%
Dividend Cover *   n/a n/a n/a n/a n/a
Revenue Per Share  163.84p 153.40p 211.32p 299.71p 262.87p
Pre-Tax Profit per Share  19.40p 25.78p 9.58p 13.67p 11.57p
Operating Margin  11.91% 16.99% 4.98% 5.94% 14.82%
Return on Capital Employed  n/a n/a n/a n/a n/a
 
Continuing & Discontinued Operations
Dividend Yield *   n/a n/a n/a n/a n/a
Dividend per Share Growth  n/a n/a n/a n/a n/a
Net Asset Value per Share (exc. Intangibles)  14.60p 19.14p -94.43p -84.82p -72.42p
Net Gearing *   n/a -7.97% 37.26% 28.79% 14.05%

Data provided by FTSE Russell




Company Information
Updated Monthly
Company address Pitcairn House, Crown Square, Centrum 100, Burton-on-Trent, DE14 2WW, United Kingdom
Company website http://www.clinigengrou...
Market cap(in millions)* £ 1,259.68
Listing/Admission to trading 25 Sep 2012
Trading service SETS
Market AIM
Listing category -
*The market capitalisation of companies reflects the London listed element only. These figures are approximate and are updated monthly.

Trading Information
18-Dec-17
FTSE index FTSE AIM All-Share,FTSE AIM 100,FTSE AIM UK 50,FTSE AIM All-Share - Health Care
FTSE sector Pharmaceuticals & Biotechnology
FTSE sub-sector Biotechnology
Country of share register GB
Segment AMSM
MiFID Status MTF
Exchange market size 2,000
SEDOL B89J241
ISIN number GB00B89J2419



CLINIGEN share fundamentals (CLIN)